GoldBamboo.com - Knowledge is strong medicine
  

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination with Prednisone - Article


  Not Signed In - Sign In / Register






Prednisone



Clinical Trial: Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination with Prednisone

This study is currently recruiting patients.

Sponsored by: Bristol-Myers Squibb
Information provided by: Bristol-Myers Squibb

Purpose

The purpose of this clinical research study is to learn whether Abatacept can treat and prevent lupus flares; specifically, active lupus flares in at least one of three organ systems: skin (discoid lesions), inflammation of the lining of the heart (pericarditis), or inflammation of the lining of the lung (pleuritis/pleurisy); or inflammation of more than 4 joints. All subjects will receive prednisone or prednisone-equivalent treatment in combination with study medication. The safety of this treatment will also be studied.
Condition Intervention Phase
Systemic Lupus Erythematosus
 Drug: Abatacept, Prednisone or Prednisone equivalent
Phase II

MedlinePlus related topics:  Lupus

Study Type: Interventional
Study Design: Treatment, Safety/Efficacy Study

Official Title: A Study of a New Drug Called Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination with Prednisone Or Prednisone-Equivalent Medication with Subsequent Taper

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Subjects must be diagnosed with SLE and be experiencing an active lupus flare in at least one of three organ systems: skin (discoid lesions), inflammation of the lining of the heart (pericarditis), or inflammation of the lining of the lung (pleuritis/pleurisy); or inflammation of more than 4 joints within 14 days of a screening visit.
  • Stable dose of prednisone (<30mg) for at least one month.

Exclusion Criteria:

  • Subjects experiencing an active lupus flare in the kidney or central nervous systems.
  • Treatment with a stable dose of azathioprine, mycophenolate mofetil, hydroxychloroquine, chloroquine, or methotrexate for less than three months prior to the study.
  • Subjects with active viral or bacterial infections.
  • Subjects with any other autoimmune disease as a main diagnosis.
  • Prior treatment with rituximab.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00119678

BMS Call Center      1-866-892-1BMS  Ext. 175 
BMS Call Center Outside the US and Canda      1-215-347-4079  Ext. 175 

Alabama
      Local Institution, Huntsville,  Alabama,  United States; Not yet recruiting

Arizona
      Local Institution, Tucson,  Arizona,  United States; Not yet recruiting

California
      Local Institution, La Jolla,  California,  United States; Not yet recruiting

      Local Institution, Long Beach,  California,  United States; Not yet recruiting

      Local Institution, Los Angeles,  California,  United States; Not yet recruiting

      Local Institution, Palo Alto,  California,  United States; Not yet recruiting

      Local Institution, San Francisco,  California,  United States; Not yet recruiting

Colorado
      Local Institution, Colorado Springs,  Colorado,  United States; Not yet recruiting

      Local Institution, Denver,  Colorado,  United States; Not yet recruiting

Florida
      Local Institution, Ft. Lauderdale,  Florida,  United States; Not yet recruiting

Illinois
      Local Institution, Chicago,  Illinois,  United States; Not yet recruiting

Indiana
      Local Institution, Evansville,  Indiana,  United States; Not yet recruiting

Kentucky
      Local Institution, Louisville,  Kentucky,  United States; Not yet recruiting

Maryland
      Local Institution, Baltimore,  Maryland,  United States; Not yet recruiting

Minnesota
      Local Institution, Minneapolis,  Minnesota,  United States; Not yet recruiting

Nevada
      Local Institution, Las Vegas,  Nevada,  United States; Not yet recruiting

New York
      Local Institution, Brooklyn,  New York,  United States; Not yet recruiting

      Local Institution, Lake Success,  New York,  United States; Not yet recruiting

      Local Institution, New York,  New York,  United States; Not yet recruiting

      Local Institution, Syracuse,  New York,  United States; Not yet recruiting

North Carolina
      Local Institution, Chapel Hill,  North Carolina,  United States; Not yet recruiting

      Local Institution, Durham,  North Carolina,  United States; Not yet recruiting

Ohio
      Local Institution, Mayfield Village,  Ohio,  United States; Not yet recruiting

Oklahoma
      Local Institution, Oklahoma City,  Oklahoma,  United States; Not yet recruiting

Pennsylvania
      Local Institution, Pittsburgh,  Pennsylvania,  United States; Not yet recruiting

South Carolina
      Local Institution, Charleston,  South Carolina,  United States; Not yet recruiting

Texas
      Local Institution, Dallas,  Texas,  United States; Not yet recruiting

      Local Institution, Sugarland,  Texas,  United States; Not yet recruiting

Wisconsin
      Local Institution, Glendale,  Wisconsin,  United States; Not yet recruiting

Australia, Queensland
      Local Institution, Cairns,  Queensland,  Australia; Not yet recruiting

      Local Institution, Cotton Tree,  Queensland,  Australia; Not yet recruiting

Australia, Victoria
      Local Institution, Clayton,  Victoria,  Australia; Not yet recruiting

      Local Institution, Heidelberg,  Victoria,  Australia; Not yet recruiting

      Local Institution, Malvern,  Victoria,  Australia; Recruiting

Austria
      Local Institution, Graz,  Austria; Not yet recruiting

      Local Institution, Wien,  Austria; Not yet recruiting

Belgium
      Local Institution, BRUXELLES,  Belgium; Not yet recruiting

      Local Institution, Leuven,  Belgium; Not yet recruiting

Brazil
      Local Institution, Sao Paulo,  Brazil; Recruiting

Brazil, Goias
      Local Institution, Goiania,  Goias,  Brazil; Not yet recruiting

Brazil, Rio De Janeiro
      Local Institution, Rio de Janeiro - RJ,  Rio De Janeiro,  Brazil; Not yet recruiting

Brazil, Rio Grande Do Sul
      Local Institution, Porto Alegre,  Rio Grande Do Sul,  Brazil; Not yet recruiting

Brazil, Sao Paulo
      Local Institution, Campinas,  Sao Paulo,  Brazil; Not yet recruiting

Canada, British Columbia
      Local Institution, Vancouver,  British Columbia,  Canada; Not yet recruiting

Canada, Ontario
      Local Institution, Toronto,  Ontario,  Canada; Not yet recruiting

Canada, Quebec
      Local Institution, Montral,  Quebec,  Canada; Not yet recruiting

France
      Local Institution, Bordeaux Cedex,  France; Not yet recruiting

      Local Institution, Lille Cedex,  France; Not yet recruiting

      Local Institution, Montpellier Cedex 5,  France; Not yet recruiting

      Local Institution, Paris Cedex 13,  France; Not yet recruiting

      Local Institution, Paris Cedex 14,  France; Not yet recruiting

      Local Institution, Strasbourg Cedex,  France; Not yet recruiting

Germany
      Local Institution, Berlin,  Germany; Not yet recruiting

      Local Institution, Dresden,  Germany; Not yet recruiting

      Local Institution, Duesseldorf,  Germany; Not yet recruiting

      Local Institution, Erlangen,  Germany; Not yet recruiting

      Local Institution, Freiburg,  Germany; Not yet recruiting

      Local Institution, Hannover,  Germany; Not yet recruiting

      Local Institution, Muenster,  Germany; Not yet recruiting

Italy
      Local Institution, Ferrara,  Italy; Not yet recruiting

      Local Institution, Milano,  Italy; Not yet recruiting

      Local Institution, Pisa,  Italy; Not yet recruiting

      Local Institution, Roma,  Italy; Not yet recruiting

Korea, Republic of
      Local Institution, Seoul,  Korea, Republic of; Recruiting

Korea, Republic of, Sungdong-Gu
      Local Institution, Seoul,  Sungdong-Gu,  Korea, Republic of; Not yet recruiting

Mexico
      Local Institution, Aguascalientes,  Mexico; Not yet recruiting

      Local Institution, Distrito Federal,  Mexico; Not yet recruiting

Mexico, Distrito Federal
      Local Institution, Mexico City,  Distrito Federal,  Mexico; Not yet recruiting

Mexico, Michioacan
      Aguascalientes, Morelia,  Michioacan,  Mexico; Not yet recruiting

Puerto Rico
      Local Institution, Ponce,  Puerto Rico; Not yet recruiting

      Local Institution, San Juan,  Puerto Rico; Not yet recruiting

South Africa, Gauteng
      Local Institution, Soweto,  Gauteng,  South Africa; Recruiting

South Africa, Kwa Zulu Natal
      Local Institution, Berea,  Kwa Zulu Natal,  South Africa; Recruiting

South Africa, West Cape
      Local Institution, Panorama,  West Cape,  South Africa; Recruiting

Sweden
      Local Institution, Lund,  Sweden; Recruiting

      Local Institution, Stockholm,  Sweden; Recruiting

Taiwan
      Local Institution, Kaohsiung,  Taiwan; Recruiting

      Local Institution, Taichung,  Taiwan; Recruiting

      Local Institution, Taipei,  Taiwan; Recruiting

United Kingdom, Greater London
      Local Institution, London,  Greater London,  United Kingdom; Not yet recruiting

United Kingdom, West Midlands
      Local Institution, Birmingham,  West Midlands,  United Kingdom; Not yet recruiting

More Information

Study ID Numbers:  IM101-042
Record last reviewed:  July 2005
Last Updated:  July 25, 2005
Record first received:  July 14, 2005
ClinicalTrials.gov Identifier:  NCT00119678
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-07-26


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Prednisone.

November 18, 2008



Page Updated: June 12, 2007
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.